Approved Symbol |
Approved Name |
Source |
Evidence[PMID] |
TNFSF4 |
tumor necrosis factor (ligand) superfamily, member 4 |
Mapped by significant region |
TAS[7913952]
|
CTF1 |
cardiotrophin 1 |
Mapped by CNV |
TAS[7862649]
|
GAB2 |
GRB2-associated binding protein 2 |
Mapped by significant region |
IDA[19172738]
|
IL6 |
interleukin 6 (interferon, beta 2) |
Mapped by significant region |
IDA[2261637]; IMP[18719127]
|
S1PR3 |
sphingosine-1-phosphate receptor 3 |
Mapped by significant region |
TAS[10617617]
|
HOXA3 |
homeobox A3 |
Mapped by significant region |
|
CCKBR |
cholecystokinin B receptor |
Mapped by CNV; Mapped by PBA pathway |
IDA[10913157]
|
TCIRG1 |
T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3 |
Mapped by significant region |
TAS[9806637]
|
ETS1 |
v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) |
Mapped by significant region |
|
TGFBR1 |
transforming growth factor, beta receptor 1 |
Mapped by significant region |
IMP[14633705]
|
FOSL1 |
FOS-like antigen 1 |
Mapped by significant region |
TAS[8230424]
|
YAP1 |
Yes-associated protein 1 |
Mapped by significant region |
|
TNC |
tenascin C |
Mapped by significant region |
|
ALDH3A1 |
aldehyde dehydrogenase 3 family, member A1 |
Mapped by significant region |
|
RPS15A |
ribosomal protein S15a |
Mapped by significant region |
IDA[15108328]
|
FGF9 |
fibroblast growth factor 9 (glia-activating factor) |
Mapped by significant region |
IDA[8321227]
|
CDC25B |
cell division cycle 25 homolog B (S. pombe) |
Mapped by CNV |
TAS[8276402]
|
CXCR2 |
chemokine (C-X-C motif) receptor 2 |
Mapped by significant region |
IDA[10438939]
|
BTC |
betacellulin |
Mapped by CNV |
|
LIFR |
leukemia inhibitory factor receptor alpha |
Mapped by significant region |
IDA[8999038]
|
TBX1 |
T-box 1 |
Mapped by CNV |
|
RPS9 |
ribosomal protein S9 |
Mapped by CNV |
IMP[18420587]
|
ACER3 |
alkaline ceramidase 3 |
Mapped by significant region |
|
EDNRA |
endothelin receptor type A |
Mapped by PBA pathway |
|
FGF4 |
fibroblast growth factor 4 |
Mapped by significant region |
IGI[8663044]
|
GREM1 |
gremlin 1 |
Mapped by CNV; Mapped by significant region |
IDA[16545136]
|
INS |
insulin |
Mapped by literature SNP |
IDA[17925406]
|
RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
Mapped by significant region |
|
CDCA7L |
cell division cycle associated 7-like |
Mapped by significant region |
IDA[15994933]
|
REG1A |
regenerating islet-derived 1 alpha |
Mapped by CNV |
TAS[2332435]
|
TNFRSF11A |
tumor necrosis factor receptor superfamily, member 11a, NFKB activator |
Mapped by CNV |
TAS[9367155]
|
CIAO1 |
cytosolic iron-sulfur protein assembly 1 |
Mapped by LD-proxy |
TAS[9556563]
|
MAPK1 |
mitogen-activated protein kinase 1 |
Mapped by LD-proxy |
|
ODC1 |
ornithine decarboxylase 1 |
Mapped by significant region |
|
LRP5 |
low density lipoprotein receptor-related protein 5 |
Mapped by CNV; Mapped by significant region |
IDA[9790987]
|
FGF3 |
fibroblast growth factor 3 |
Mapped by significant region |
IGI[8663044]
|
CAV3 |
caveolin 3 |
Mapped by LD-proxy; Mapped by literature SNP |
|
CHRM1 |
cholinergic receptor, muscarinic 1 |
Mapped by PBA pathway; Mapped by significant region |
TAS[2739737]
|
BIRC6 |
baculoviral IAP repeat containing 6 |
Mapped by CNV |
|
IGF2 |
insulin-like growth factor 2 (somatomedin A) |
Mapped by LD-proxy; Mapped by literature SNP |
IC[11500939]
|
FLT4 |
fms-related tyrosine kinase 4 |
Mapped by CNV |
IGI[11574540]; IMP[19779139]
|
CLCF1 |
cardiotrophin-like cytokine factor 1 |
Mapped by significant region |
IDA[11285233]
|
FGF19 |
fibroblast growth factor 19 |
Mapped by significant region |
IGI[18187602]
|
PDCD10 |
programmed cell death 10 |
Mapped by CNV |
IDA[17360971]
|
CTGF |
connective tissue growth factor |
Mapped by significant region |
|
CAPN1 |
calpain 1, (mu/I) large subunit |
Mapped by significant region |
TAS[8702541]
|
MTA3 |
metastasis associated 1 family, member 3 |
Mapped by LD-proxy; Mapped by literature SNP |
|
ADAM17 |
ADAM metallopeptidase domain 17 |
Mapped by significant region |
IMP[18373975]
|
SHMT2 |
serine hydroxymethyltransferase 2 (mitochondrial) |
Mapped by CNV |
|
ILK |
integrin-linked kinase |
Mapped by CNV |
|
MVD |
mevalonate (diphospho) decarboxylase |
Mapped by significant region |
IMP[9270019]
|
OSMR |
oncostatin M receptor |
Mapped by significant region |
IGI[8999038]
|
TTK |
TTK protein kinase |
Mapped by PBA pathway |
TAS[1639825]
|
PRKAA1 |
protein kinase, AMP-activated, alpha 1 catalytic subunit |
Mapped by significant region |
|